Chinese medicine compound for lung adenocarcinoma treatment for inducing cell autophagy and reducing cell growth, expansion and metastasis capability to treat lung adenocarcinoma
A Chinese medicine compound for lung adenocarcinoma treatment contains radix polygalae, rhizoma atractylodis macrocephalae, angelica sinensis, poria cocos, astragalus, spina date seed, radices saussureae, prepared radix glycyrrhizae and dried ginger. The aforementioned material are together processed through a water quenching process and filtered out the dregs to obtain a water quenching medicinal solution. The dregs are then processed through an alcohol quenching process and filtered out the dregs to obtain an alcohol quenching medicinal solution and, mixing the water quenching medicinal solution with the alcohol quenching medicinal solution. In which, the compound may employ a newly discovered protein delivery model for performing a target enzyme screening for important enzymes. It is found that some single prescriptions of Chinese medicine have different inhibitory effects on different organ cells, which can successfully induce the cell autophagy, reduce the cell growth, expansion and metastasis capability, thereby achieving the treatment effect for lung adenocarcinoma and the treatment progressivity.一種可治療肺腺癌之中葯複方,其中包括:遠志、白朮、當歸、茯神、黃耆、酸棗仁、黨參、木香、炙甘草及生薑,上述之葯材,合經一水淬程序過濾出葯渣,得一水淬葯湯,取其葯渣經一酒淬程序濾出葯渣,得到一酒淬葯湯;將上述水淬葯湯與酒淬葯湯混合。其中,該複方係由一新發現的蛋白輸送模式,針對重要酵素進行目標酵素篩檢,並發現部分中葯單方在不同器官細胞有不同抑制功能之效用,能夠成功引起細胞自噬、降低細胞生長、擴張及轉移能力之效果,而達到治療肺腺癌之功效,具治療進步性達成者。
